Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial

JAMA

Volumn 283, Issue 21, 2000, Pages 2795-2801

  MacLennan, Jenny M ^a   Shackley, Fiona ^a,e   Heath, Paul T ^a,f   Deeks, Jonathan J ^b   Flamank, Caroline ^a   Herbert, Mark ^a   Griffiths, Helen ^a   Hatzmann, Eva ^c   Goilav, Christian ^d   Moxon, E Richard ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Chiron Vaccines   (Netherlands)

^d CHIRON VACCINES   (Italy)

^e ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; MENINGOCOCCUS VACCINE;

ANTIBODY TITER; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EATING DISORDER; ERYTHEMA; FEMALE; FEVER; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INFANT; MALE; MENINGITIS; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NORMAL HUMAN; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SOMNOLENCE; VACCINATION; VOMITING;

EID: 0034616767     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.21.2795     Document Type: Article

References (23)

1. Invasive Haemophilus influenzae infections: changing patterns. Commun Dis Rep CDR Rev. 1994;4: 227.
2. Ramsey M, Kaczmarski EB, Rush M, Mallard R, Farrington P, White J. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun Dis Rep CDR Rev. 1997; 7:R49-R54.
3. Kaczmarski EB. Meningococcal disease in England and Wales: 1995. Commun Dis Rep CDR Rev. 1997; 7:R55-R59.
4. Gotschlich EC, Goldschneider I, Artenstein MS. Human immunity to the meningococcus, V. J Exp Med. 1969;129:1385-1395.
5. Ceesay SJ, Allen SJ, Menon A, et al. Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. J Infect Dis. 1993;167:1212-1216.
6. Reingold AL, Broome CV, Hightower AW, et al. Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide vaccine. Lancet. 1985;2:114-118.
7. Gold R, Lepow ML, Goldschneider I, Gotschlich EC. Immune response of human infants to polysaccharide vaccines of group A and C Neisseria meningitidis. J Infect Dis. 1977;136(suppl):S31-S35.
8. Leach A, Twumasi PA, Kumah S, et al. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis. 1997;175:200-204.
9. MacDonald NE, Halperin S, Law B, Forrest BD, Danzig LE, Granoff DM. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial. JAMA. 1998;280:1685-1689.
10. Granoff DM, Gupta RK, Belshe RB, Anderson EL. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. J Infect Dis. 1998;178:870-874.
11. Siber GR. Pneumococcal disease: prospects for a new generation of vaccines. Science. 1994;265:1385-1387.
12. Steward MW, Lew AM. The importance of antibody affinity in the performance of immunoassays for antibody. J Immunol Methods. 1985;78:173-190.
13. 197. J Immunol. 1989;142:2464-2468.
14. Twumasi PA Jr, Kumah S, Leach A, et al. A trial of a group A plus group C meningococcal polysacchande-protein conjugate vaccine in African infants. J Infect Dis. 1995;171:632-638.
15. Fairley CK, Begg N, Borrow R, Fox AJ, Jones DM, Cartwright K. Conjugate meningococcal serogroup A and C vaccine. J Infect Dis. 1996;174:1360-1363.
16. Granoff DM, Maslanka SE, Carlone GM, et al. A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses. Clin Diagn Lab Immunol. 1998;5:479-485.
17. Griffiths H, Lea J, Bunch C, Lee M, Chapel H. Predictors of infection in chronic lymphocytic leukaemia (CLL). Clin Exp Immunol. 1992;89:374-377.
18. Booy R, Taylor SA, Dobson SR, et al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch Dis Child. 1992;67:475-478.
19. Miller E, Ashworth LA, Robinson A, Waight PA, Irons Ll. Phase II trial of whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogens. Lancet. 1991;337:70-73.
20. Wood DJ, Heath AB. The Second International Standard for anti-poliovirus sera types 1, 2 and 3. Biologicals. 1992;20:203-211.
21. STATA Statistical Software [computer program]. Release 5.0. College Station, Tex: STATA Corp; 1997.
22. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus, I: the role of humoral antibodies. J Exp Med. 1969;129:1307-1326.
23. Milagres LG, Lemos AP, Meles CE, et al. Antibody response after immunization of Brazilian children with serogroup C meningococcal polysaccharide noncovalently complexed with outer membrane proteins. Braz J Med Biol Res. 1995;28:981-989.